Megan Meyers focuses on patent litigation, specifically Abbreviated New Drug Application (ANDA) matters at the district court level and in appeals to the U.S. Court of Appeals for the Federal Circuit, as well as patent prosecution and client counseling. She has experience representing pharmaceutical patent holders in ANDA and 505(b)(2) application litigations arising under the Hatch-Waxman Act. Megan has technical experience in the biomedical field, including technologies such as prosthetic limbs and orthotic devices.
During law school, Megan completed a certificate program focused on advising biology Ph.D. students on intellectual property matters, including patentability, freedom-to-operate, and obtaining protection for their technologies. The program also involved analyzing the commercialization of the researchers’ innovative technologies. Megan also worked as an analyst for an angel investing group that evaluates startup companies for investment potential, including the strength of their patent portfolios.
While completing her undergraduate degrees, Megan worked in a prosthetics and orthotics lab, which allowed her to gain experience with the fabrication of various medical devices. Megan manages the Drugs section of the firm’s IP FDA blog, where she identifies topics for blog posts and assists in editing and coordinating the publication of these posts. She has used her knowledge of the Food & Drug Administration and Orange Book procedures to assist in client counseling regarding these topics.
Megan has a passion for pro bono work. While in law school, she worked with the Health Law Partnership, a branch of Atlanta Legal Aid that partners with impoverished families and children who are patients at Children’s Healthcare of Atlanta. Her work with these families included addressing landlord/tenant issues, Supplemental Security Income (SSI), disability, and family law matters. As a summer associate at Finnegan, Megan wrote a brief to file with the U.S. Court of Appeals for Veterans Claims on behalf of an injured veteran. She continues to successfully represent injured veterans as an associate with the firm.
